Related Experiment Video
Updated: Sep 29, 2026

Quantifying Glomerular Permeability of Fluorescent Macromolecules Using 2-Photon Microscopy in Munich Wistar Rats
Published on: April 17, 2013
Exogenous albumin peptides influence the processing of albumin during renal passage
Gabriela A Eppel1, Lynette M Pratt, Kerryn A Greive
1Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic., Australia.
Unlabelled:
Exogenous albumin peptides influence the processing of albumin during renal passage.
Background/Aims:
This study investigates the hypothesis that there will be peptide regions in albumin that will effectively compete for the receptors associated with the renal processing of albumin.
Methods:
We employ albumin peptides prepared from albumin by trypsin digestion. The presentation of the exogenous peptides along with intact [(3)H]albumin to the kidney was made by intravenous injection into rats. The excretion rate and integrity of urinary [(3)H]albumin was measured. Similar experiments were performed with the use of gelatin peptides produced by trypsin digestion as controls. The formation of [(3)H]albumin derived fragments by extrarenal sources was also examined in rats with nonfiltering kidneys.
Results:
In the presence of exogenous albumin-derived peptides there was a significant increase in the proportion of larger [(3)H]albumin fragments in the urine. This is a reversible effect. There was no significant change when gelatin peptides were used. The albumin peptides also increase the fractional clearance of [(3)H]albumin. There were no [(3)H]albumin-derived fragments produced in plasma over a 4-hour circulation period in rats with nonfiltering kidneys.
Conclusions:
This study demonstrates that albumin fragments, which are produced by the kidney and not by extrarenal sources, are exclusively excreted in the urine. Exogenous albumin peptides were able to specifically exert a competitive effect on the renal enzyme cleavage of intact albumin.
More Related Videos
Related Concept Videos
Drug Distribution: Plasma Protein Binding
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Drug Elimination by Renal Route: Tubular Secretion
Renal Drug Excretion: Tubular Secretion
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...

